Pluri vs ProKidney
PLUR and PROK side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How PLUR and PROK compare
ProKidney is the larger company, worth 23 times as much as Pluri ($342M against $14.8M).
ProKidney grew revenue faster over the last twelve months (55.2% versus −24.0% for Pluri).
Pluri keeps more of each dollar of sales as profit, with a net margin of −2345% compared with −10288% at ProKidney.
ProKidney scores higher on the StockData Score (5 against 2 for Pluri), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | PLUR | PROK |
|---|---|---|
| Size and price | ||
| Market cap | $14.8M | $342M |
| Share price | $1.20 | $1.13 |
| Change, 1 year | −69.2% | −58.1% |
| Change, 5 years | −94.3% | −88.6% |
| Beta (5Y) | 0.97 | 1.32 |
| Employees | 92 | 231 |
| StockData Score | ||
| Total score | 2 | 5 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 0 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 14.6× (better) | 418× |
| FCF yield | −137% | −46.8% (better) |
| Growth | ||
| Revenue growth (TTM) | −24.0% | 55.2% (better) |
| Profitability | ||
| Gross margin | 44.6% | – |
| Operating margin | −2455% (better) | −21665% |
| Net margin | −2345% (better) | −10288% |
| FCF margin | −1990% (better) | −19527% |
| Financial health | ||
| Interest coverage | −26.8× (better) | −9327.2× |
| Current ratio | 0.27 | 8.36 (better) |
| Altman Z-score | −30.49 | −1.12 (better) |
| Piotroski F-score | 1 | 2 (better) |
| Dividends and buybacks | ||
| Buyback yield | −34.3% | −7.1% (better) |
| Shareholder yield | −34.3% | −7.1% (better) |
| Ownership | ||
| Held by institutions | 0.22% | 16.1% |
| Held by insiders | 54.6% | 62.9% |
| Insider net buying, 12 months | $1.3M (better) | −$1.1M |
| Short interest, % of float | 1.4% | 21.7% |
Go deeper
- PLUR stock overview
- PLUR income statement
- PLUR valuation and score
- PROK stock overview
- PROK income statement
- PROK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.